Related references
Note: Only part of the references are listed.Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
Veronique Minard-Colin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
Nancy L. Bartlett et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
Christopher Melani et al.
HAEMATOLOGICA (2018)
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
Christopher Melani et al.
HAEMATOLOGICA (2018)
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R
Lisa Giulino-Roth et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy
Mary Gerrard et al.
BLOOD (2013)
Therapy in Primary Mediastinal B-Cell Lymphoma
[Anonymous]
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
Kieron Dunleavy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study
M. Rieger et al.
ANNALS OF ONCOLOGY (2011)
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children
Ilske Oschlies et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence
B Burkhardt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Long-term results of the first Italian Association of Pediatric Hematology and Oncology Protocol for the Treatment of Pediatric B-Cell Non-Hodgkin Lymphoma (AIEOP LNH92)
M Pillon et al.
CANCER (2004)
Primary mediastinal large B-Cell lymphoma with sclerosis in pediatric and adolescent patients: Treatment and results from three therapeutic studies of the Berlin-Frankfurt-munster Group
K Seidemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy
WH Wilson et al.
BLOOD (2002)
Share Paper
